Bayer's 2024 annual results showed a 2.2% sales decline, with only free cash flow improving significantly. Read why BAYZF ...

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

a lack of physician education has been one of the reasons biosimilar uptake has been slower in the US. Manufacturers can work with a commercialisation partner to build provider confidence through ...

Merck KGaA operates in three key segments: healthcare, life science, and electronics. Over the past decade, strategic acquisitions and divestments have strengthened its position in these industries, ...

As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

The ACA has touched the lives of every American, proving that improving the U.S. health system is possible. It can, and ...

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of ...

The life sciences are experiencing a shifting landscape of rapid technological innovation and volatile market conditions that companies in the sector must be ready to adapt to, according to a new ...